Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Computations for group sequential boundaries using the Lan-DeMets spending function method.

D M Reboussin1, D L DeMets, K M Kim

  • 1Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC, USA.

Controlled Clinical Trials
|May 24, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

When treatment takes a turn: tocilizumab-induced bowel perforation in a patient with COVID-19-afflicted rheumatoid arthritis.

Scandinavian journal of rheumatology·2024
Same author

Arterial Spin-Labeling MR Imaging for the Differential Diagnosis of Venous-Predominant AVMs and Developmental Venous Anomalies.

AJNR. American journal of neuroradiology·2023
Same author

Risk Factors Affecting Complications of Access Site in Vascular Intervention through Common Femoral Artery.

Nigerian journal of clinical practice·2022
Same author

Immune response to hepatitis B vaccination and factors associated with poor immune response among healthcare workers.

Nigerian journal of clinical practice·2021
Same author

Clinical significance of heat shock protein 90α expression as a biomarker of prognosis in patients with gastric cancer.

Nigerian journal of clinical practice·2019
Same author

Phase lag entropy as a hypnotic depth indicator during propofol sedation.

Anaesthesia·2019
Same journal

On the generation and ownership of alpha in medical studies.

Controlled clinical trials·2004
Same journal

An analysis of the effect of funding source in randomized clinical trials of second generation antipsychotics for the treatment of schizophrenia.

Controlled clinical trials·2004
Same journal

Symptom recording in a randomised clinical trial: paper diaries vs. electronic or telephone data capture.

Controlled clinical trials·2004
Same journal

Statistical comparison of random allocation methods in cancer clinical trials.

Controlled clinical trials·2004
Same journal

Analyzing bronchodilation with emphasis on disease type, age and sex.

Controlled clinical trials·2004
Same journal

Geographic variability in patient characteristics, treatment and outcome in an International Trial of Magnesium in acute myocardial infarction.

Controlled clinical trials·2004
See all related articles

This study introduces a Fortran program for group sequential clinical trial design and analysis using Lan-DeMets spending functions. The software handles flexible interim analyses, avoiding type I error inflation for robust trial management.

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Statistical Software

Background:

  • Clinical trials frequently incorporate interim analyses of accumulating data.
  • Group sequential methods are essential to prevent type I error rate inflation during these analyses.
  • Existing methods often require pre-specified, equally spaced interim analyses.

Purpose of the Study:

  • To present an interactive Fortran program for designing and analyzing group sequential clinical trials.
  • To implement Lan-DeMets spending functions for flexible alpha allocation.
  • To provide a computational tool for various aspects of group sequential trial analysis.

Main Methods:

  • Development of an interactive Fortran program.
  • Utilizes Lan-DeMets spending functions for alpha distribution.

Related Experiment Videos

  • Applies computations suitable for multivariate normal test statistics with independent increments.

    • Main Results:

    • The program accommodates non-equally spaced interim analyses.
    • The number of interim analyses does not need to be pre-specified.
    • The software can determine sequential boundaries, compute power, probabilities, and confidence intervals.

    Conclusions:

    • The developed Fortran program offers a flexible and robust tool for group sequential clinical trial design and analysis.
    • It addresses limitations of traditional methods by allowing flexible interim analysis timing and quantity.
    • The program supports critical trial design and analysis computations, enhancing statistical rigor.